Impact of BMI and comorbidities on efficacy of once‐weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial

BM McGowan, A Houshmand‐Oeregaard… - …, 2023 - Wiley Online Library
Objective This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …
被引用次数：6 相关文章
[PDF] siditalia.it

[PDF][PDF] Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial

BM McGowan, A Houshmand-Oeregaard, PN Laursen… - 2023 - siditalia.it
Objective: This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …

Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial

BM McGowan, A Houshmand-Oeregaard, PN Laursen… - 2023 - pubmed.ncbi.nlm.nih.gov
Objective This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …

Impact of BMI and comorbidities on efficacy of once‐weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.

BM McGowan, A Houshmand‐Oeregaard… - Obesity …, 2023 - search.ebscohost.com
Objective: This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …

Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial

BM McGowan, A Houshmand-Oeregaard… - …, 2023 - search.proquest.com
Objective: This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …

Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.

BM McGowan, A Houshmand-Oeregaard… - Obesity (Silver Spring …, 2023 - europepmc.org
Objective This study assessed the effects of semaglutide on body weight, cardiometabolic
risk factors, and glycemic status in individuals categorized by baseline BMI with or without …